EICHORCondition: Prostate Cancer · Sponsor: Eli Lilly and Company
Sponsor, CRO or site team? See where this study is running → — listed sites, countries and recruiting context. Everything below is written for patients and caregivers.
This study is being done to see how safe and effective abemaciclib is when given together with abiraterone acetate plus prednisone in participants with metastatic castration resistant prostate cancer. Prednisolone may be used instead of prednisone per local regulation.
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
| St. Joseph's Hospital and Medical Center | Phoenix, Arizona, United States | — |
| Mayo Clinic in Arizona - Phoenix | Phoenix, Arizona, United States | — |
| The University of Arizona Cancer Center - North Campus | Tucson, Arizona, United States | — |
| St. Bernards Medical Center | Jonesboro, Arkansas, United States | — |
| CBCC Global Research, Inc. | Bakersfield, California, United States | — |
| Providence St. Jude Medical Center | Fullerton, California, United States | — |
| Moores Cancer Center | La Jolla, California, United States | — |
| TRIO-US (Translational Research in Oncology-US) | Los Angeles, California, United States | — |
| UCLA Hematology/Oncology - Westwood (Building 100) | Los Angeles, California, United States | — |
| Pacific Cancer Care | Monterey, California, United States | — |
| Sansum Clinic_Kendle | Santa Barbara, California, United States | — |
| Rocky Mountain Cancer Center | Lone Tree, Colorado, United States | — |
+ 100 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03706365